AstraZeneca PLC Total Voting Rights Notification

SEC Filing 6-K (0001654954-25-008838)

AstraZeneca PLC has submitted a Form 6-K to the SEC, notifying the total voting rights as of 31 July 2025. The company reported that it has 1,550,682,580 ordinary shares with voting rights, each valued at US$0.25. No shares are held in Treasury, making the total number of voting rights in AstraZeneca PLC 1,550,682,580. This information is provided in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. Shareholders can use this figure to determine if they need to notify their interest or any changes in their interest in AstraZeneca PLC under the UK Financial Conduct Authority's Disclosure and Transparency Rules. AstraZeneca is a global biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines in various therapeutic areas.